These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3524923)

  • 1. Clinical and morphologic evolution of idiopathic membranous nephropathy.
    Zucchelli P; Cagnoli L; Pasquali S; Casanova S; Donini U
    Clin Nephrol; 1986 Jun; 25(6):282-8. PubMed ID: 3524923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
    Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
    N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B
    N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
    Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome.
    Zucchelli P; Ponticelli C; Cagnoli L; Passerini P
    Nephrol Dial Transplant; 1987; 2(2):73-8. PubMed ID: 3112653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
    Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
    Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
    [No Abstract]   [Full Text] [Related]  

  • 10. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advantages of immunosuppressive therapy in renal disease.
    Zucchelli P
    Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
    Ardiles LG; Mezzano SA
    Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M; Grcevska L; Dzikova S
    Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand.
    Panomsak S; Lewsuwan S; Eiam-Ong S; Kanjanabuch T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S151-6. PubMed ID: 17044467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.